Data gathered: April 15
AI Stock Analysis - Illumina (ILMN)
Analysis generated October 1, 2024. Powered by Chat GPT.
Illumina, Inc., a leading developer in the field of biotechnology, specializes in the area of DNA sequencing and array-based technologies. The company provides various solutions for genetic research, clinical diagnostics, agricultural genomics, and personal genomics. Known for its innovative platforms which include next-generation sequencing (NGS) systems, Illumina significantly contributes to scientific research, diagnostics, and the advancement of personalized medicine.
Stock Alerts - Illumina (ILMN)
 |
Illumina | April 10 Price is down by -6.1% in the last 24h. |
|
Illumina | April 9 Price is up by 5.7% in the last 24h. |
|
Illumina | April 8 Price is down by -5% in the last 24h. |
|
Illumina | April 7 Price is down by -5.9% in the last 24h. |
Alternative Data for Illumina
About Illumina
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
| Price | $75.06 |
| Target Price | Sign up |
| Volume | 2,860,000 |
| Market Cap | $11.9B |
| Year Range | $70.3 - $155.15 |
| Dividend Yield | 0% |
| Analyst Rating | 50% buy |
| Earnings Date | May 8 '25 |
| Industry | Biotechnology |
In the news
 |
Illumina price target lowered by $15 at BofA, here's whyApril 14 - Thefly.com |
 |
Wells Fargo & Company MN Has $17.83 Million Stock Position in Illumina, Inc. (NASDAQ:ILMN)April 14 - ETF Daily News |
|
Wellington Management Group LLP Decreases Position in Illumina, Inc. (NASDAQ:ILMN)April 12 - ETF Daily News |
Single-cell Omics Emerging Technologies and Markets Report 2025: 10x Genomics, Thermo Fisher & Illumina Lead $9.1 Billion Single-cell Omics Market by 2029April 10 - GlobeNewswire |
|
 |
Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025April 10 - Yahoo |
|
Illumina (NASDAQ:ILMN) Reaches New 12-Month Low on Analyst DowngradeApril 9 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 1.08B | 335M | 745M | 705M | 758M | 1.140 |
| Q2 '24 | 1.11B | 391M | 721M | -1.99B | -1.59B | 0.360 |
| Q1 '24 | 1.08B | 409M | 667M | -126M | -42M | 0.090 |
| Q4 '23 | 1.12B | 448M | 674M | -176M | -100M | 0.140 |
| Q3 '23 | 1.12B | 435M | 684M | -754M | -714M | 0.330 |
Insider Transactions View All
| Thaysen Jacob filed to buy 14,861 shares at $137.2. February 26 '24 |
| Thaysen Jacob filed to buy 14,169 shares at $135.7. February 26 '24 |
| Thaysen Jacob filed to buy 12,616 shares at $134.9. February 26 '24 |
| Hoyt Aimee L filed to sell 8,314 shares at $112.8. November 9 '23 |
| TOUSI SUSAN H filed to sell 45,524 shares at $167. August 24 '23 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rohit Khanna Democrat |
Jun 5, 24 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Jun 5, 24 | Sell | $1K - $15K |
| Thomas Kean Jr Republican |
May 30, 24 | Buy | $1K - $15K |
Read more about Illumina (ILMN) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Illumina?
The Market Cap of Illumina is $11.9B.
When does Illumina report earnings?
Illumina will report its next earnings on May 8 '25.
What is the current stock price of Illumina?
Currently, the price of one share of Illumina stock is $75.06.
How can I analyze the ILMN stock price chart for investment decisions?
The ILMN stock price chart above provides a comprehensive visual representation of Illumina's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Illumina shares. Our platform offers an up-to-date ILMN stock price chart, along with technical data analysis and alternative data insights.
Does ILMN offer dividends to its shareholders?
As of our latest update, Illumina (ILMN) does not offer dividends to its shareholders. Investors interested in Illumina should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Illumina?
Some of the similar stocks of Illumina are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.